298. The Neuroscience of Antidepressants Part 2: The Glutamate Hypothesis

In part 2 of my Neuroscience episodes about antidepressants I’m diving into the Glutamate Hypothesis. I chat about the role of the glutamatergic system within the brain in helping us to better understand why some people don’t respond well to the first line of treatments, such as SSRIs. I’m also diving into treatment resistant depression, electro convulsive therapy (ECT) neuroplasticity and transcranial magnetic stimulation. LINKS: Listen to Part 1 of this series The Neuroscience of Anti-Depressants: The Monoamine Hypothesis at https://pod.fo/e/21783a . Read the paper ‘Glutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization’ accessible via PUBMED https://tr.ee/glutamatergic-paper . Listen to episode 50. Stress on the brain and how to reverse its effects at https://pod.fo/e/1f8306 . Listen to episode 257 my episode on Ketamine as a treatment for depression here https://bit.ly/Dyfm-ketamine. Join the DYFM Facebook Group https://bit.ly/dyfm-group . Follow @dyfmpodcast on IG  Follow @alexispredez on IG   Follow @listnrentertainment on IG  CREDITS Host: Alexis Fernandez       Executive Producer & Editor: Elise CooperDigital Producer: Zoe Panaretos DYFM Social Producer: Shania MaguaManaging Producer: Sam Cavanagh  Find more great podcasts like this at www.listnr.com/   See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.